DOI: https://doi.org/10.14739/2310-1210.2014.2.25436

Другие специфические типы сахарного диабета

V. G. Kadzharyan, A. I. Melnyk, P. P. Bidzilya, A. O. Solovyuk

Аннотация


За последнее десятилетие стало очевидно, что не все случаи диабета, развившегося в детском, подростковом и более старшем возрасте, являются диабетом 1 и 2 типов. У пациентов удается чаще идентифицировать MODY и LADA тип диабета, а также более редкие синдромальные формы. В статье описан современный взгляд на этиологию, патогенез, клинику и диагностику MODY и LADA диабетов, что дает возможность точной постановки диагноза и назначения пациенту патогенетической терапии.


Ключевые слова


MODY диабет; LADA диабет

Полный текст:

PDF

Литература


Barret T.G., Ehtisham S. The emergence of type 2 diabetes in childhood. Ann. Clin. Biochem 2004; 41: 10-16

Fajans S.S., Conn J.W. The use of tolbutamidein the treatment of young people with mild diabetes mellitus - a progressreport. Diabetes 1962;11:123-126.

Tattersall R.B., Mansell P.I. Maturity onsettypediabetes of the young (MODY): one condition or many. Diabet Med 1991;8:402–410

Barret T.G. Differential diagnosis of type 1 diabetes: which genetic syndromes need to be considered. Pediatric Diabetes. 2007; 8(149): 15-23.

Bell G.L., Xiang K.-S., Newman M.V. et al. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc. Natl. Acad. Sci. USA 1991;88: 1484-1488.

Njolstad P.R., Molven A, Sovik O. Chiarelli F., Dahl-Jogensen K., Kiess W. Karger. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity. In «Diabetes in childhood and Adolescence» 2005; 86-93.

Tattersall R.B., Fajans S.S. A difference betweenthe inheritance of classical juvenileonsetand maturity-onset type diabetes of young people. Diabetes 1975; 24: 44-53

Owen K.R., Thanabalasingham G., JamesT.J. et al. Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminatorof maturity-onset diabetes of the young due to HNF1A mutations. DiabetesCare 2010; 33:1919–1924

Froguel P., Zouali H., Vionnet N. Familial hyperglycaemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N. Engl. J. Med. 1993;328: 697-702.

Shih D.Q., Dansky H.M., Fleisher M.,Assmann G., Fajans S.S., Stoffel M. Genotype (phenotype) relationships in HNF-4a MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein(CIII), lipoprotein(a), and triglyceridelevels. Diabetes 2000;49: 832–837.

Hattersley A., Bruining J., Shield J.,Njolstad P.,Donaghue K.C. The diagnosis and managementof monogenic diabetes in childrenand adolescents. Pediatr. Diabetes. 2009;10(Suppl. 12):33–42

Cuesta-Muñoz A.L., Tuomi T., Cobo-Vuilleumier N., et al. Clinical heterogeneityin monogenic diabetes caused by mutations in the glucokinase gene (GCKMODY).Diabetes Care 2010;33:290–292

The Diabetes Prevention Trials- Type 1Study Group. Effects of oral insulin in relatives of patients with type 1 Diabetes. Diabetes Care 2005; 28: 1068-1076.

Fajans S.S., Bell G.I. Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees. Diabetologia 2006;49:1106–1108

Raeder, H., Johansson, S., Holm, P.I., Haldorsen, I.S., Mas, E., Sbarra, V., Nermoen, I., Eide, S.A., Grevle, L., Bjørkhaug, L., Sagen, J.V., Aksnes, L., Søvik, O., Lombardo, D., Molven, A., Njølstad, P.R. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nat. Genet. 2006; 1-18.

Palmer J.P., Hirsch I.B. What’s in a name: latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes. Diabetes Care 2003; 26: 536—538.

Pozzilli P., Di Mario U. Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care. 2001; 24: 1460—1467.

Zimmet P.Z., Tuomi T., Mackay I.R. et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet.Med. 1994; 11 : 299—303.

Borg H., Gottsäter A., Fernlund P., Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002; 51: 1754—1762.

Kobayashi T., Tamemoto K., Nakanishi K. et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care. 1993; 16: 780—788.

Tuomi T., Carlsson A., Li H. et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999; 48: 150—157.

Turner R., Stratton I., Horton V. et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet.1997; 350: 1288—1293.

Hosszufalusi N., Vatay A., Rajczy K. et al. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 2003; 26: 452—457.

Кононенко И.В. Функциональное состояние β-клеток, периферическая чувствительность к инсулину, метаболизм глюкозы у больных с поздним аутоиммунным началом сахарного диабета в дебюте заболевания. Автореф. дис. канд. мед. наук. М. 2003; 21.

Cervin C., Lyssenko V., Bakhtadze E. et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 2008; 57: 1433—1437.

Brusko T.M., Wasserfall C.H., Clare-Salzler M.J. et al. Functional defects and the influence of age on the frequency of CD+4CD+25 T-cells in type 1 diabetes. Diabetes 2005; 54: 1407—1414.

Tang Q., Bluestone J.A. Regulatory T-cell physiology application to treat autoimmunity. Immunol. Rev. 2006; 212: 217—237.

Lindley S., Dayan C.M., Bishop A. et al. Defective suppressor function in CD4+CD25+ T cells from patients with type 1 diabetes. Diabetes 2005; 54: 92–99.

Tabeeva KI . V. Nikonov, OM Smirnov. Polyglandular autoimmune syndrome type III (DTZ, type 1 diabetes, autoimmune glomerulonephritis). Diabetes 2004, 4: 30-32.

Nikonov TV, Apanovich PV, EV Pekareva et al. Immunogenetic aspects of slowly progressive autoimmune diabetes in adults (LADA). Diabetes in 2011, 1: 28-33


Ссылки

  • На текущий момент ссылки отсутствуют.


Запорожский медицинский журнал   Лицензия Creative Commons
Запорожский государственный медицинский университет